Global Peptide Antibiotics Market Examined & Forecast by Kuick Research in Its New Report Now Available at MarketPublishers.com

03 Aug 2017 • by Natalie Aster

LONDON – In the offing, peptide antibiotics are anticipated to emerge as novel growth frontier for different stakeholders engaged in the R&D of antibiotics. Whilst the era of “classical antibiotics” is reaching its end given problems like heavy resistance to conventional antibiotics, the novel era of peptide antibiotics is expected to revolutionise the antibiotics industry. The peptide antibiotics hold the dominant position amid new generation medications, and are predicted to storm the markets in the years ahead.

At present, antibiotics are the key revenue source for most PharmaCos. The demand for antibiotics is surging with many companies heavily investing in the growth of the antibiotics market. Globally, the demand for antibiotics is anticipated to exceed USD 40 billion by the year 2023; in comparison it stands at appr. USD 30 billion in the current year.

Today, there are 6 commercially available peptide antibiotics in the marketplace, and 24 peptide antibiotics are in clinical pipeline. The US takes lead in the world production and commercialization of peptide antibiotics, it is followed by Europe. Vicuron Pharmaceuticals and Theravance are the key American companies active in the peptide antibiotics field. Their leadership in the world market is predicted to remain stable in the years ahead. However, the developing countries like India and China are expected to make the impressive contribution to the overall antibiotics market growth in the coming years.

The cutting-edge report “Global Peptide Antibiotics Market & Clinical Pipeline Insight 2023”  made up by Kuick Research presents access to an all-round overview of the major non-clinical and clinical parameters responsible for the development and commercialization of the world’s peptide antibiotics market. This publication uncovers reliable statistics on the industry performance, gives vital data on the marketed products and products under development, discusses the most recent industry innovations and development, touches upon the prevailing and emerging trends. Many other important data on the peptide antibiotics market performance and a future outlook through 2023 are at hand in this study.

Follow to the Kuick Research catalogue to find a full collection of the publisher’s research reports.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com